Methylnaltrexone Bromide

CAS 916055-92-0 4 current records 2 historicalSmall Molecule

Who holds supplier records for Methylnaltrexone Bromide? 4 organisations hold a current record for Methylnaltrexone Bromide: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: United States (1) and India (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Methylnaltrexone Bromide: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/methylnaltrexone-bromide

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Methylnaltrexone Bromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

United States1India1Country not recorded for 2
  • CHONGQING LAND TOWER PHARMACEUTICAL CO LTD
    Active DMF 30173 · latest filing Dec 2016
  • NORAMCO INC
    Active DMF 26528 · latest filing Sept 2012
    United States
  • SIEGFRIED GRAFTON INC
    Active DMF 31803 · latest filing Mar 2020
  • Sun Pharmaceutical Industries Limited
    Active DMF 42782 · latest filing Dec 2025
    India Company GMP cert on record
Need Methylnaltrexone Bromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Methylnaltrexone Bromide are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • United States · Inactive DMF 15837 · filed Jan 2002
  • MALLINCKRODT CHEMICAL INC
    Inactive DMF 8948 · filed Jan 1991

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Methylnaltrexone Bromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201770).

Chemical identity

IUPAC name
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one bromide
Canonical SMILES
C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6.[Br-]
InChIKey
IFGIYSGOEZJNBE-KNLJMPJLSA-N
Synonyms
Bromure de methylnaltrexone, Bromuro de metilnaltrexona, Methylnaltrexone bromide, Moa-728, MOA728, MRZ 2663BR, MRZ-2663BR, MRZ2663BR, Naltrexone methobromide, Naltrexone methylbromide, N-methylnaltrexone bromide, Relistor

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Opioid Antagonist
Mechanism of action
Opioid Antagonists
Chemical structure
Quaternary Ammonium Compounds

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Methylnaltrexone Bromide?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Methylnaltrexone Bromide: CHONGQING LAND TOWER PHARMACEUTICAL CO LTD, NORAMCO INC (United States), SIEGFRIED GRAFTON INC and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Methylnaltrexone Bromide Drug Master Files are active?

CHONGQING LAND TOWER PHARMACEUTICAL CO LTD (DMF 30173), NORAMCO INC (DMF 26528), SIEGFRIED GRAFTON INC (DMF 31803) and Sun Pharmaceutical Industries Limited (DMF 42782). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Methylnaltrexone Bromide records mean?

2 organisations have only inactive Type II DMFs for Methylnaltrexone Bromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Methylnaltrexone Bromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Methylnaltrexone Bromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.